Senior Director, Strategic Product Planning - Rare Disease

About Acadia Pharmaceuticals

Acadia is advancing breakthroughs in neuroscience to elevate life. For 30 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson’s disease psychosis and the first and only FDA-approved drug for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on Prader-Willi syndrome, Alzheimer’s disease psychosis and multiple other programs targeting neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at Acadia.com and follow us on LinkedIn and X.

Please note that this position is based in either San Diego, CA. Acadia's hybrid model requires this role to work in our office three days per week on average.

Responsible for leading strategic direction for Acadia’s current and future  designated portfolio.  This includes utilizing data and market knowledge to identify and initiate optimal approaches to both current product value and future areas of opportunity.  Lead internal cross functional commercialization subteams and manage external agencies to ensure stakeholder alignment.  Also a key contributor to analyses and strategic insights to inform the clinical and commercial development of rare disease pipeline products, as well as collaboratively building sound commercial assessments of potential new disease assets for the organization. 

Primary Responsibilities

• Develops the long-range commercial launch plan for the U.S. and other key global markets, including brand growth strategies and tactics that target HCPs, patients & caregivers.
• Lead commercial strategy for Phase 3 pipeline products, including audience definition and segmentation, value proposition, branding, positioning, and key messaging.
• Manages productive external relationships with Key Opinion Leaders and Congress leadership.
• Works with Access & Reimbursement, Medical Affairs and HEOR to develop differentiation, as well as effective strategies and tactics designed to secure appropriate market access for investigational disease products in the portfolio.
• Manages relationships with key vendors/consultants in support of core HCP/patient/caregiver audience needs and conduct yearly assessments as needed.
• Assumes overall brand budget accountability and manages promotional spend forecasts; works with finance to monitor spending against budget/forecast; Identifies trends and insights to optimize spend, performance, and ROI.
• Ensures close collaboration with Patient Services and Patient Advocacy to identify and address key areas of need and to ensure optimal level of engagement and support for the relevant patient and caregiver communities.
• Develop analysis of target markets to determine current and future treatment paradigms, competitive landscape, unmet need, product positioning and value proposition, making commercial judgements around implications.
• Drive development of and maintenance of strategic target product profiles (TPPs) for pipeline assets in conjunction with program teams.
• Provides strategic direction on market research objectives, designs and interpretation to Inform brand strategies.
• Informs the commercialization plan for potential new assets, particularly as it relates to resource needs and overall market opportunity (i.e. sales force sizing requirements, identification of target patient populations, HCPs, access strategy)
• Identifies, analyzes, and translates relevant clinical and landscape data, as well as competitive intelligence, to inform the development of asset strategies and BD opportunities
• Conducts market/commercial assessment, including forecasts, for BD opportunities with a focus on rare opportunities based on market research, secondary research, and internal subject matter expert collaboration.
• Assumes program/brand budget accountability for strategic product p